Work Area: IP public policy

Latest content

The EU’s UPC launch is imminent – here’s what IP strategists need to know

Companies must now make tough decisions about which rights to opt out of the new unified European patent system

25 January 2022

Biden administration is right to pursue a ‘China Initiative’ reset

Even some of the programme’s architects seem to agree that it has strayed from initial focus on trade secrets and intellectual property

22 January 2022

Discretionary denials impact US life sciences IP strategies, but not as much as might be thought

SCOTUS refuses to consider NHK-Fintiv legal challenges, with significant implications for PTAB actions

20 January 2022

USPTO reports strong finances despite a fall in patent filings

Increased fees helped the office's budget escape unscathed from a drop in applications, and the agency expects 1.5% growth in patenting this year

19 January 2022

Japan mulls paying companies to keep sensitive patents under wraps

Economic security law proposed by Japanese government would place restrictions on disclosing patents related to sensitive technologies and innovations

19 January 2022

WHO’s vaccine successes show significance of Moderna covid IP pledge

African tech transfer hub is making fast progress in replicating the approved mRNA jab

18 January 2022

Draft Biden SEP policy favours implementers, but even they may still flock to other jurisdictions

Finnegan attorneys Erik Puknys and Michelle Rice explain that while the proposed DOJ/NIST/USPTO FRAND framework is good for implementers, it may not be enough to make the US stand out in global forum competition

17 January 2022

Tencent, Vivo among biggest risers as Chinese patent grants continue to grow

The number of invention patents and utility models issued by the CNIPA both surged by more than 30% last year, while PCT filings levelled off

11 January 2022

AbbVie heads to the ITC in dramatic final battle over Humira biosimilars

Chicago-based company seeking to exclude Alvotech’s adalimumab product from the US market for alleged trade secret misappropriation

10 January 2022

Vidal USPTO Director confirmation vote cancelled, but not due to opposition to her appointment

The Senate Judiciary Committee is all set to endorse her appointment but has been delayed in doing thanks to a funeral and a riot’s anniversary

06 January 2022

Get unlimited access to all IAM content